Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) Interest & Investment Income (2016 - 2025)

National Healthcare's Interest & Investment Income history spans 12 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 6.14% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $9.8 million, down 2.55%, while the annual FY2025 figure was $9.8 million, 2.57% down from the prior year.
  • Interest & Investment Income reached $2.5 million in Q4 2025 per NHC's latest filing, down from $2.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.8 million in Q4 2023 to a low of $982000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $1.9 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: decreased 28.48% in 2022, then skyrocketed 80.03% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $982000.0 in 2021, then surged by 59.06% to $1.6 million in 2022, then surged by 80.03% to $2.8 million in 2023, then dropped by 17.71% to $2.3 million in 2024, then increased by 6.14% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for NHC's Interest & Investment Income are $2.5 million (Q4 2025), $2.7 million (Q3 2025), and $2.6 million (Q2 2025).